ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 59 filers reported holding ATRECA INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,620 | -73.4% | 362,530 | 0.0% | 0.00% | -62.5% |
| Q2 2023 | $355,279 | -14.0% | 362,530 | 0.0% | 0.01% | -20.0% |
| Q1 2023 | $413,284 | +42.4% | 362,530 | 0.0% | 0.01% | +42.9% |
| Q4 2022 | $290,242 | -60.0% | 362,530 | -21.6% | 0.01% | -63.2% |
| Q3 2022 | $726,000 | -12.3% | 462,530 | 0.0% | 0.02% | -20.8% |
| Q2 2022 | $828,000 | -43.5% | 462,530 | 0.0% | 0.02% | -35.1% |
| Q1 2022 | $1,466,000 | +4.6% | 462,530 | 0.0% | 0.04% | +15.6% |
| Q4 2021 | $1,401,000 | -51.1% | 462,530 | +0.6% | 0.03% | -46.7% |
| Q3 2021 | $2,865,000 | -26.9% | 459,830 | 0.0% | 0.06% | -22.1% |
| Q2 2021 | $3,918,000 | -43.7% | 459,830 | +1.3% | 0.08% | -49.3% |
| Q1 2021 | $6,959,000 | -4.5% | 453,930 | +0.6% | 0.15% | -1.9% |
| Q4 2020 | $7,287,000 | +15.7% | 451,230 | +0.1% | 0.16% | -3.1% |
| Q3 2020 | $6,298,000 | – | 450,830 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,396,644 | $23,000,000 | 5.25% |
| EcoR1 Capital, LLC | 2,426,685 | $39,191,000 | 2.11% |
| Boxer Capital, LLC | 2,202,333 | $35,568,000 | 1.14% |
| Aisling Capital Management LP | 387,653 | $6,261,000 | 1.08% |
| CM Management, LLC | 60,000 | $969,000 | 0.90% |
| Samsara BioCapital, LLC | 474,943 | $7,670,000 | 0.77% |
| Parkman Healthcare Partners LLC | 126,258 | $2,039,000 | 0.52% |
| Redmile Group, LLC | 2,476,068 | $39,988,000 | 0.48% |
| Sio Capital Management, LLC | 128,455 | $2,075,000 | 0.42% |
| HighVista Strategies LLC | 30,824 | $498,000 | 0.32% |